HNN3.0
Register
Register
Register

Project cooperationUpdated on 28 October 2026

Analytical Partner: UHPLC-MS/MS Profiling & Bioactivity Assessment for Health Consortia

Senior researcher at Lithuanian university of health sciences

Kaunas, Lithuania

About

Partner Expertise & Call Contribution

The Lithuanian University of Health Sciences (LSMU), Institute of Pharmaceutical Technologies, offers specialized expertise to address complex analytical and screening challenges in Horizon Europe Cluster 6 / Health consortia.

We bridge high-resolution analytical chemistry with pharmacological validation to support drug discovery, natural product development, standardized extract characterization, and safety/efficacy assessments.

Core Analytical & Research Capabilities:

  • Chromatography & Mass Spectrometry: Development and validation of UHPLC, HPLC, and LC-MS/MS methods for complex biological and botanical matrices.

  • Chemical Profiling & Quality Control: Detailed qualitative and quantitative characterization of active pharmaceutical ingredients (APIs), secondary metabolites, and target bioactive compounds.

  • In Vitro Bioactivity Screening: Cell-based and biochemical assays evaluating antioxidant, anti-inflammatory, cytotoxic, and pharmacological properties.

  • Preclinical & Formulation Support: Stability testing, extract standardization, and analytical quality control for novel therapeutic and health-related formulations.

Role in Project:

  • Work Package (WP) Leader or Partner in analytical methodology, bioactivity screening, and quality control.

  • Data interpretation and reporting compliant with European standards and open-access research practices.

Contact: Dr. Vaidotas Žvikas, LSMU Institute of Pharmaceutical Technologies.

Similar opportunities